Clinical trial

A Study in Non Small Cell Lung Cancer

NCT01139775

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-02-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2011-02-01Date precision: month

Registry last updated2018-05-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non Small Cell Lung Cancerunresolved

Interventions

PemetrexedDRUG · verified · RxNorm: pemetrexed

CisplatinDRUG · verified · RxNorm: cisplatin

LY2603618DRUG

Sponsors & collaborators

Eli Lilly and Companylead sponsor

Mapped research locations

MadridSpain3 BarcelonaSpain3 BerlinGermany1 SevilleSpain1 HanoverGermany1 HeidelbergGermany1 FrankfurtGermany1 MainzGermany1 UlmGermany1 LübeckGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01139775 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.